At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Placebo-controlled, Double-blinded Cross-over Study of the Pharmacologic Action of a GPR119 Agonist on Glucagon Counter-regulation During Insulin-induced Hypoglycemia in Type 1 Diabetes Mellitus
In Brief
A Phase 2 clinical trial evaluating Placebo, Study Medication (MBX-2982), and 1 other intervention for Diabetes Mellitus, Type 1. Completed, enrolled 110 participants across 1 site.
Detailed Summary
The purpose of this study is to test if a specific research medication could increase the response to low blood glucose in people with type 1 diabetes. The response of the body to low blood sugar will be measured in healthy people as a reference point.
Study Details
Timeline
Interventions
Each group will receive either a pill that contains the study medication (MBX-2982) or a pill that does not contain the medication (placebo)
Each group will receive either a pill that contains the study medication (MBX-2982) or a pill that does not contain the medication (placebo)
This group will be studied to establish the norm of the measurement that will be performed to obtain the study outcomes.